LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 38.51 | 17.25 | 2647 | 2906 | 0.9109 | 0.9749 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 38.51 | 17.25 | 2248 | 2906 | 0.7736 | 0.9318 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 38.51 | 17.25 | 3536 | 2906 | 1.2168 | 1.0538 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 40.48 | 17.25 | 1 | 3125 | 0.0003 | -0.3159 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 40.48 | 17.25 | 2863 | 3125 | 0.9159 | 0.9767 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 40.48 | 17.25 | 2450 | 3125 | 0.7838 | 0.9361 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 40.48 | 17.25 | 3798 | 3125 | 1.2151 | 1.0526 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 42.45 | 17.25 | 1 | 3504 | 0.0003 | -0.3103 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 42.45 | 17.25 | 3121 | 3504 | 0.8907 | 0.9700 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 42.45 | 17.25 | 2560 | 3504 | 0.7306 | 0.9198 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 42.45 | 17.25 | 4203 | 3504 | 1.1995 | 1.0480 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 44.42 | 17.25 | 1 | 3895 | 0.0003 | -0.3053 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 44.42 | 17.25 | 3377 | 3895 | 0.8669 | 0.9638 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 44.42 | 17.25 | 2766 | 3895 | 0.7100 | 0.9143 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 44.42 | 17.25 | 4666 | 3895 | 1.1977 | 1.0467 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 46.39 | 17.25 | 1 | 4141 | 0.0002 | -0.3024 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 46.39 | 17.25 | 3700 | 4141 | 0.8934 | 0.9717 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 46.39 | 17.25 | 2858 | 4141 | 0.6901 | 0.9083 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 46.39 | 17.25 | 5096 | 4141 | 1.2305 | 1.0531 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 48.36 | 17.25 | 1 | 4390 | 0.0002 | -0.2998 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 48.36 | 17.25 | 3994 | 4390 | 0.9097 | 0.9765 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 48.36 | 17.25 | 3506 | 4390 | 0.7986 | 0.9445 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 48.36 | 17.25 | 5447 | 4390 | 1.2407 | 1.0547 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 50.33 | 17.25 | 3 | 4651 | 0.0006 | -0.1948 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 50.33 | 17.25 | 4375 | 4651 | 0.9406 | 0.9849 | MN20160310_N02 | F15 |